Purilogics Overview
- Year Founded
-
2013

- Status
-
Acquired/Merged
- Employees
-
8

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$48.9M
Purilogics General Information
Description
Developer of disposable membrane chromatography columns designed to purify biologics for research and early-stage drug trials. The company's columns are used for the downstream purification of a range of therapeutic agents that include monoclonal antibodies, recombinant and fusion proteins, enabling researchers to improve the speed of early-stage development to get biologics to market faster where they are needed, to serve the large and growing population of patients with long-term, chronic conditions such as cancers, cardiovascular diseases and autoimmune disorders.
Contact Information
(Operating Subsidiary)
- ITOR 900B West Faris Road
- Greenville, SC 29605
- United States
Purilogics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Merger/Acquisition | 13-Jun-2022 | $48.9M | 000.00 | Completed | Generating Revenue | |
7. Grant | 01-Aug-2021 | 00000 | Completed | Generating Revenue | ||
6. Grant | 01-Aug-2021 | 00000 | Completed | Generating Revenue | ||
5. Grant | 30-Aug-2018 | 00000 | Completed | Generating Revenue | ||
4. Grant | 01-Jan-2017 | 00.000 | Completed | Generating Revenue | ||
3. Grant | 01-Jan-2016 | 00000 | Completed | Generating Revenue | ||
2. Accelerator/Incubator | 16-Apr-2015 | Completed | Startup | |||
1. Grant | $80K | Completed | Startup |
Purilogics Comparisons
Industry
Financing
Details
Purilogics Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cambrex | Private Equity-Backed | East Rutherford, NJ | 0000 | 00000 | 000000000 | 00000 |
0000000000 | Corporate Backed or Acquired | Torrance, CA | 000 | 000000&0 |
Purilogics Patents
Purilogics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20230010637-A1 | Epoxide-activated substrates and hydrophobic interaction chromatography made therefrom for polynucleotide purification | Pending | 12-Jul-2021 | 00000000 |
Purilogics Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Jinxiang Zhou Ph.D | Co-Founder & Director | ||
Scott Husson Ph.D | Co-Founder |
Purilogics Signals
Purilogics Former Investors (9)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Clemson University Foundation | Limited Partner | 000 0000 | 000000 0 | ||
Groupe Michelin | Corporation | 000 0000 | 000000 0 | ||
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
National Science Foundation | Government | 000 0000 | 000000 0 | ||
SC EPSCoR/IDeA Foundation | Government | 000 0000 | 000000 0 |